找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Handbook of Biologics for Rheumatological Disorders; Neeraj Jain,Lalit Duggal Book 2022 The Editor(s) (if applicable) and The Author(s), u

[复制链接]
查看: 30321|回复: 61
发表于 2025-3-21 17:44:33 | 显示全部楼层 |阅读模式
书目名称Handbook of Biologics for Rheumatological Disorders
编辑Neeraj Jain,Lalit Duggal
视频video
概述Provides the rational behind use of biologics in rheumatoid diseases.Investigates the current treatment regime of existing biologics.Addresses the concerns of biologics toxicity
图书封面Titlebook: Handbook of Biologics for Rheumatological Disorders;  Neeraj Jain,Lalit Duggal Book 2022 The Editor(s) (if applicable) and The Author(s), u
描述Biologics have revolutionized the treatment of autoimmune diseases due to their efficacy, speed of onset, and tolerability. The development of new agents and expanded use of existing agents continues to be a highly active area of investigation among rheumatic diseases, with a multitude of innovative therapeutic strategies in various stages of development. Although the story of treatments continues rapidly, therapeutic research in some conditions is hindered by the rarity of the disease, variation in phenotype, and concerns about toxicity. This fast-paced development of therapeutics,necessitates immediate evaluation  of individual biologic  agents and their best use in the new treatment regimens..This book provides an inclusive approach with the existing evidence concerning effectiveness and implications on the usage of biologics in treating various rheumatologic disorders. It also covers the evidence behind the rational use of these agents in varied autoimmune diseases. This manual also offers a complete overview of the existing & futuristic biologic treatments, and draws recommendations on how to standardize the most suitable regimen for a specific patient in the context of curren
出版日期Book 2022
关键词Psoriatic Arthritis; Spondyloarthritis; Rheumatoid Arthritis; Gout; Sarcaidosis
版次1
doihttps://doi.org/10.1007/978-981-16-7200-2
isbn_softcover978-981-16-7202-6
isbn_ebook978-981-16-7200-2
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor
The information of publication is updating

书目名称Handbook of Biologics for Rheumatological Disorders影响因子(影响力)




书目名称Handbook of Biologics for Rheumatological Disorders影响因子(影响力)学科排名




书目名称Handbook of Biologics for Rheumatological Disorders网络公开度




书目名称Handbook of Biologics for Rheumatological Disorders网络公开度学科排名




书目名称Handbook of Biologics for Rheumatological Disorders被引频次




书目名称Handbook of Biologics for Rheumatological Disorders被引频次学科排名




书目名称Handbook of Biologics for Rheumatological Disorders年度引用




书目名称Handbook of Biologics for Rheumatological Disorders年度引用学科排名




书目名称Handbook of Biologics for Rheumatological Disorders读者反馈




书目名称Handbook of Biologics for Rheumatological Disorders读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:11:24 | 显示全部楼层
Biologics in Rheumatoid Arthritis,ombination with hydroxychloroquine (200 mg/day), oral methotrexate (15 mg/week) and leflunomide (10 mg/day). Her physician hikes her disease modifying anti rheumatic drug (DMARD) doses to hydroxychloroquine (400 mg/day), subcutaneous methotrexate (25 mg/week) and leflunomide (20 mg/day) and adds low
发表于 2025-3-22 00:56:54 | 显示全部楼层
Biologics in Spondyloarthritis,vent. They are the single most effective treatment option by a distance for axial SpA (axSpA), where the science of rheumatology had found itself limited until a couple of decades back. Apart from their numero uno position in the management of Ankylosing Spondylitis (AS), they are also very effectiv
发表于 2025-3-22 07:45:07 | 显示全部楼层
Biologics in Psoriatic Arthritis, enthesitis, dactylitis, skin and nail disease [1, 2]. Treatment of PsA has witnessed a sea change over the past two decades. Extra-articular manifestations including uveitis and inflammatory bowel disease, and comorbidities like obesity, metabolic disease and depression play critical roles in treat
发表于 2025-3-22 10:35:33 | 显示全部楼层
Biologics in Gout,t. For the vast majority of patients, such therapy is sufficient to “cure” gout. Pegloticase, a biologic urate-lowering drug is in consideration when conventional urate-lowering treatments (ULTs) are ineffective due to inefficacy, intolerance, or contraindications. Similarly, low-dose prednisolone,
发表于 2025-3-22 14:23:33 | 显示全部楼层
Biologics in Systemic Lupus Erythematosus (SLE),e is characterized by periods of flare and remission, leading to accrual of damage in multiple organ systems, which is contributed by ongoing disease activity and treatment-related toxicities. More effective but less toxic therapies are unmet needs for the management of SLE. A number of novel agents
发表于 2025-3-22 18:24:17 | 显示全部楼层
发表于 2025-3-22 21:33:30 | 显示全部楼层
发表于 2025-3-23 03:54:13 | 显示全部楼层
Biologics in Idiopathic Inflammatory Myopathies,Treatable subtype of IIM include (juvenile) dermatomyositis ((j)DM), antisynthetase syndrome (ASS), immune-mediated necrotizing myopathy (IMNM) and overlap/non-specific myositis [OM/NSM, formerly called polymyositis (PM)]. Treatment of Idiopathic inflammatory myositis (IIMs), is not only long and of
发表于 2025-3-23 08:47:01 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-10 16:08
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表